AstraZeneca PLC is 150.1x more valuable than Lakefront Biotherapeutics NV by market capitalization ($286.27 B vs $1.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LKFT | AZN |
|---|---|---|
| Market cap | $1.91 B | $286.27 B |
| US-listed rank | #2140 | #47 |
| SEC filings | 511 | 1,004 |
AstraZeneca PLC is 150.1x more valuable than Lakefront Biotherapeutics NV by market capitalization ($286.27 B vs $1.91 B).
Full pages: Lakefront Biotherapeutics NV and AstraZeneca PLC, or browse the full rankings.